Seiji Yano
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Treatments and Mutations 79
- Occupational and environmental lung diseases 13
- Oncology 86
- Lung Cancer Research Studies 22
- Pancreatic and Hepatic Oncology Research 12
- Peptidase Inhibition and Analysis 12
- Co-authors
- Saburo Sone (65 shared papers)Tadaaki Yamada (57 shared papers)Yasuhiko Nishioka (35 shared papers)Shinji Takeuchi (65 shared papers)Kunio Matsumoto (24 shared papers)Wei Wang (16 shared papers)Masahiro Fukuoka (3 shared papers)Kazuhiko Nakagawa (4 shared papers)
- Journals
- Cancer Science (23 papers)Clinical Cancer Research (16 papers)International Journal of Cancer (10 papers)The Journal of Medical Investigation (9 papers)Journal of Thoracic Oncology (8 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Seiji Yano
251 papers receiving 11.1k citations
Seiji Yano's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 4.8k
- Pulmonary and Respiratory Medicine 5.0k
- Cancer Research 1.6k
- Hepatology 498
- Molecular Biology 4.3k
Countries citing papers authored by Seiji Yano
This map shows the geographic impact of Seiji Yano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Yano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Yano more than expected).
Fields of papers citing papers by Seiji Yano
This network shows the impact of papers produced by Seiji Yano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Yano. The network helps show where Seiji Yano may publish in the future.
Co-authors
The 25 scholars most cited alongside Seiji Yano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 268 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer Hit paper breakdown → | 2003 | 2525 |
| 2 | Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations Hit paper breakdown → | 2008 | 547 |
| 3 | 2002 | 364 | |
| 4 | Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. | 2000 | 325 |
| 5 | 2019 | 279 | |
| 6 | 2009 | 254 | |
| 7 | 2019 | 227 | |
| 8 | 2011 | 197 | |
| 9 | 2013 | 185 | |
| 10 | 2004 | 145 | |
| 11 | 2013 | 142 | |
| 12 | 2000 | 141 | |
| 13 | Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. | 2000 | 140 |
| 14 | 2016 | 133 | |
| 15 | 2015 | 125 | |
| 16 | 2012 | 106 | |
| 17 | 2011 | 98 | |
| 18 | Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. | 2000 | 97 |
| 19 | 2005 | 97 | |
| 20 | 2020 | 97 |
About Seiji Yano
Seiji Yano is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Hepatology, having authored 268 papers that have together received 11.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (79 papers), Lung Cancer Research Studies (22 papers), PI3K/AKT/mTOR signaling in cancer (19 papers), Occupational and environmental lung diseases (13 papers), Angiogenesis and VEGF in Cancer (13 papers), Pancreatic and Hepatic Oncology Research (12 papers), Peptidase Inhibition and Analysis (12 papers) and Liver physiology and pathology (11 papers). The work is most often cited by research in Oncology (4.8k citations), Pulmonary and Respiratory Medicine (5.0k citations), Cancer Research (1.6k citations), Hepatology (498 citations) and Molecular Biology (4.3k citations). Seiji Yano has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Saburo Sone, Tadaaki Yamada, Yasuhiko Nishioka, Shinji Takeuchi, Kunio Matsumoto, Wei Wang, Masahiro Fukuoka, Kazuhiko Nakagawa, Shinzoh Kudoh and Isaiah J. Fidler. Their work appears in journals such as Cancer Science, Clinical Cancer Research, International Journal of Cancer, The Journal of Medical Investigation and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.